Bauman JE, Karam SD, O'Brien C, Mak G, et al. Durvalumab in combination with chemoradiotherapy in patients with head and neck squamous cell carcinoma: Results from the Phase 1 CLOVER study. Head Neck 2024 Mar 17. doi: 10.1002/hed.27726.
PMID: 38494597